Second, BPC 157 therapy implements Folkman’s cornea concept (cornea neovascularization goes with tumor growth; inhibited corneal neovascularization, inhibited tumor growth) [7,8,9], and exhibits a particular anti-tumor effect in the human melanoma cell line, it inhibits the VEGF effect [16], attributed to controlling the VEGF system as well [16]. Here, VEGFA is linked to melanoma.